SIVmac239 MVA Vaccine with and without a DNA Prime, Similar Prevention of Infection by a Repeated Dose SIVsmE660 Challenge Despite Different Immune Responses

BACKGROUND: Vaccine regimens using different agents for priming and boosting have become popular for enhancing T cell and Ab responses elicited by candidate HIV/AIDS vaccines. Here we use a simian model to evaluate immunogenicity and protective efficacy of a recombinant modified vaccinia Ankara (MVA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lai, Lilin, Kwa, Sue-Fen, Kozlowski, Pamela A., Montefiori, David C., Nolen, Tracy, Hudgens, Michael G., Johnson, Welkin E., Ferrari, Guido, Hirsch, Vanessa M., Felber, Barbara K., Pavlakis, George N., Earl, Patricia L., Moss, Bernard, Amara, Rama Rao, Robinson, Harriet L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278564/
https://ncbi.nlm.nih.gov/pubmed/22178526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.12.026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge